Table 1.
Inhibitor | Products with wt IN | Products with N155H IN | Products with Q148H IN | |||||
---|---|---|---|---|---|---|---|---|
FS | DD | CHS | FS | DD | CHS | FS | CHS | |
EVG | 8.5 ± 1.3 | 8.6 ± 1.2 | 145 ± 5 | 87 ± 7.5 | 62 ± 24 | 250 ± 24 | 173 ± 50 | 230 ± 29 |
RAL | 21 ± 4 | 14 ± 2.5 | 246 ± 81 | 68 ± 15 | 58 ± 15 | 160 ± 71 | 341 ± 69 | 222 ± 45 |
MK-2048 | 42 ± 5 | 21 ± 3 | 365 ± 45 | 42 ± 3 | 26 ± 8 | 171 ± 27 | 97 ± 29 | 122 ± 31 |
RDS 1997 | 90 ± 24 | 66 ± 18 | 352 ± 49 | 150 ± 32 | 87 ± 12 | 245 ± 60 | 500 ± 58 | 363 ± 95 |
RDS 2197 | 495 ± 76 | 347 ± 42 | 1757 ± 362 | 395 ± 48 | 260 ± 91 | 622 ± 164 | 1021 ± 186 | 822 ± 180 |
The IN-DNA complexes were assembled with IN (20 nM) and 5′-32P end-labeled 1.6 kb U5 substrate (0.5 nM) at 14°C for 15 min. Increasing concentrations of inhibitor along with the supercoiled DNA (1.5 nM) were added and strand transfer was carried out for 2 h at 37°C. In the reactions with N155H and Q148H IN, 30 nM of protein was added and strand transfer was carried out for 3 h at 37°C. The samples were deproteinized and subjected to 0.7% agarose gel electrophoresis. The quantity of each type of product (FS, D-D and CHS) was determined by Image-Quant 5.2 and the inhibition of each product was calculated. The IC50 (nM) for each DNA product with each inhibitor was determined from at least three independent experiments.